Number of Shares
154,693.00
Current Holdings Value*
$114.79 Mil
% of Portfolio
10.33%
Total Estimate Gain
$3.55 Mil
% of Total Estimate Gain
3.51%

Bronte Capital Management Pty Ltd.'s Regeneron Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Bronte Capital Management Pty Ltd. held 154,693.00 shares of Regeneron Pharmaceuticals Inc(REGN), totaling $114.79 Mil. This investment constitutes 10.33% of their stock portfolio, and Bronte Capital Management Pty Ltd. now holds 0.14% of the outstanding Regeneron Pharmaceuticals Inc(REGN) stock.

The initial trade took place in 2020Q4. And since then Bronte Capital Management Pty Ltd. has made 12 purchases of REGN, at an average price of $574.38, for a total of 175,888.00 shares. In addition, there have been 6 sales at an average price of $840.01 for 21,195.00 shares. Based on historical transaction data and REGN's current price of $560.93, Bronte Capital Management Pty Ltd.'s estimated gain on his REGN holdings is $3.55 Mil, reflecting a 3.51% gain to date.

Bronte Capital Management Pty Ltd. REGN ($560.93) Holding Chart

Bronte Capital Management Pty Ltd. REGN ($560.93) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1